Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04073615
Title Phase 1b/2 Study of Rivoceranib and Trifluridine/Tipiracil for Metastatic Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors LSK BioPartners Inc.
Indications

colorectal cancer

Therapies

Rivoceranib + Trifluridine-tipiracil hydrochloride

Rivoceranib

Trifluridine-tipiracil hydrochloride

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.